These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 6201857)
1. Immunity and protection against influenza virus by synthetic peptide corresponding to antigenic sites of hemagglutinin. Shapira M; Jibson M; Muller G; Arnon R Proc Natl Acad Sci U S A; 1984 Apr; 81(8):2461-5. PubMed ID: 6201857 [TBL] [Abstract][Full Text] [Related]
2. [Antigenic properties of synthetic fragments of the heavy chain of influenza virus A hemagglutinin]. Samukov VV; Mazurkova NA; Kalashnikov VV; Ofitserov VI; Shval'e AF Mol Gen Mikrobiol Virusol; 1988 Jul; (7):35-9. PubMed ID: 2461511 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of loop-structured short synthetic peptides mimicking the antigenic site A of influenza virus hemagglutinin. Schulze-Gahmen U; Klenk HD; Beyreuther K Eur J Biochem; 1986 Sep; 159(2):283-9. PubMed ID: 2428615 [TBL] [Abstract][Full Text] [Related]
4. Antibodies elicited by influenza virus hemagglutinin fail to bind to synthetic peptides representing putative antigenic sites. Nestorowicz A; Tregear GW; Southwell CN; Martyn J; Murray JM; White DO; Jackson DC Mol Immunol; 1985 Feb; 22(2):145-54. PubMed ID: 2579329 [TBL] [Abstract][Full Text] [Related]
5. Recombinant protein comprising multi-neutralizing epitopes induced high titer of antibodies against influenza A virus. Li H; Ding J; Chen YH Immunobiology; 2003; 207(5):305-13. PubMed ID: 14575146 [TBL] [Abstract][Full Text] [Related]
6. Characterizing immunodominant and protective influenza hemagglutinin epitopes by functional activity and relative binding to major histocompatibility complex class II sites. Rajnavölgyi E; Horváth A; Gogolák P; Tóth GK; Fazekas G; Fridkin M; Pecht I Eur J Immunol; 1997 Dec; 27(12):3105-14. PubMed ID: 9464794 [TBL] [Abstract][Full Text] [Related]
7. Specificity and cross-reactivity of synthetic peptides derived from a major antigenic site of influenza hemagglutinin. Shapira M; Misulovin Z; Arnon R Mol Immunol; 1985 Jan; 22(1):23-8. PubMed ID: 2579325 [TBL] [Abstract][Full Text] [Related]
8. [Hemagglutinin antigenic determinants of Hong Kong influenza viruses and their role in creating resistance to influenza infection]. Platonova AL; Isaeva EI; Rovnova ZI; Kosiakov PN Vopr Virusol; 1980; (6):712-5. PubMed ID: 6164164 [No Abstract] [Full Text] [Related]
9. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin. Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221 [TBL] [Abstract][Full Text] [Related]
10. Localization, synthesis, and activity of an antigenic site on influenza virus hemagglutinin. Atassi MZ; Webster RG Proc Natl Acad Sci U S A; 1983 Feb; 80(3):840-4. PubMed ID: 6187004 [TBL] [Abstract][Full Text] [Related]
11. [Immunogenic properties of synthetic fragments of influenza virus hemagglutinin, conjugated with a carrier protein]. Mazurkova NA; Samukov VV; Podcherniaeva RIa Vopr Virusol; 1989; 34(1):34-8. PubMed ID: 2728405 [TBL] [Abstract][Full Text] [Related]
12. Anti-influenza response achieved by immunization with a synthetic conjugate. Müller GM; Shapira M; Arnon R Proc Natl Acad Sci U S A; 1982 Jan; 79(2):569-73. PubMed ID: 6176996 [TBL] [Abstract][Full Text] [Related]
13. Antigenic activity of a synthetic peptide comprising the "loop" region of influenza virus hemagglutinin. Jackson DC; Murray JM; White DO; Fagan CN; Tregear GW Virology; 1982 Jul; 120(1):273-6. PubMed ID: 6179292 [No Abstract] [Full Text] [Related]
14. Protection against multiple subtypes of influenza viruses by virus-like particle vaccines based on a hemagglutinin conserved epitope. Chen S; Zheng D; Li C; Zhang W; Xu W; Liu X; Fang F; Chen Z Biomed Res Int; 2015; 2015():901817. PubMed ID: 25767809 [TBL] [Abstract][Full Text] [Related]
15. Broadly protective monoclonal antibodies against H3 influenza viruses following sequential immunization with different hemagglutinins. Wang TT; Tan GS; Hai R; Pica N; Petersen E; Moran TM; Palese P PLoS Pathog; 2010 Feb; 6(2):e1000796. PubMed ID: 20195520 [TBL] [Abstract][Full Text] [Related]
16. I-Ad restricted T cell recognition of influenza hemagglutinin. Synthetic peptides identify multiple epitopes corresponding to antibody-binding regions of the HA1 subunit. Barnett BC; Burt DS; Graham CM; Warren AP; Skehel JJ; Thomas DB J Immunol; 1989 Oct; 143(8):2663-9. PubMed ID: 2477451 [TBL] [Abstract][Full Text] [Related]
17. [Protective action of cytotoxic lymphocytes depending on the antigenic determinant composition of influenza virus hemagglutinin]. Berdinskikh MS; Kiseleva AS; Kosiakov PN Biull Eksp Biol Med; 1989 Oct; 108(10):471-2. PubMed ID: 2480826 [TBL] [Abstract][Full Text] [Related]
18. [Importance of cross-reacting antibodies in creating resistance to influenza]. Platonova AL Vopr Virusol; 1981; (6):709-12. PubMed ID: 6175111 [TBL] [Abstract][Full Text] [Related]
19. Changes in the antigenicity of the hemagglutinin molecule of H3 influenza virus at acidic pH. Webster RG; Brown LE; Jackson DC Virology; 1983 Apr; 126(2):587-99. PubMed ID: 6190310 [TBL] [Abstract][Full Text] [Related]
20. [Immunological study of antigenic determinants in the isolated hemagglutinin of the influenza A virus (H1N1)]. Isaeva EI; Ignat'eva TV; Rovnova ZI Vopr Virusol; 1986; 31(3):283-8. PubMed ID: 2429447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]